Literature DB >> 10429834

Zanamivir. A potent and selective inhibitor of influenza A and B viruses.

F Y Aoki1, F G Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10429834

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  2 in total

Review 1.  Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.

Authors:  Jennifer A Pickens; Ralph A Tripp
Journal:  Viruses       Date:  2018-01-21       Impact factor: 5.048

2.  Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.

Authors:  Eric H Holmes; Harikrishna Devalapally; Libin Li; Michael L Perdue; Gary K Ostrander
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.